Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
207,440,936
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
3,430,835
-
Shares change
-
+46,342
-
Total reported value, excl. options
-
$51,872,345
-
Value change
-
+$961,180
-
Number of buys
-
18
-
Number of sells
-
-22
-
Price
-
$15.12
Significant Holders of Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) as of Q1 2014
48 filings reported holding ESPR - Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2014.
Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,430,835 shares
of 207,440,936 outstanding shares and own 1.7% of the company stock.
Largest 10 shareholders include Pentwater Capital Management LP (886,224 shares), WASATCH ADVISORS INC (606,564 shares), Polar Capital LLP (403,940 shares), BlackRock Fund Advisors (322,343 shares), MORGAN STANLEY (167,458 shares), VANGUARD GROUP INC (158,717 shares), Iguana Healthcare Management, LLC (135,000 shares), FMR LLC (89,100 shares), MILLENNIUM MANAGEMENT LLC (78,181 shares), and BlackRock Institutional Trust Company, N.A. (74,565 shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.